Back to News
Market Impact: 0.15
Sangamo Therapeutics, Inc. Files Monthly Operating Reports and Closes $161 million in Asset Sales
Source: Nasdaq
Legal & LitigationHealthcare & BiotechCompany Fundamentals
Sangamo Therapeutics filed monthly operating reports with the U.S. Bankruptcy Court for the District of Delaware for July, August, and September 2026. The article text is truncated and provides no financial figures or further details about the proceedings.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
SGMOQ-0.30
More News
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- SK Hynix Posts Record Profit Amid AI Rush
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- VCs will make billions on Anthropic’s IPO, but Amazon is set to make much (much) more
- Analysis-Hold or sell? High Treasury yields spur US banks to rethink bond portfolios
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Stop Treating AI Like a Chatbot: What Are Agents, SubAgents, MCP, and Skills, and How Do They Actually Work?
- Equity Research Automation Statistics: A 2026 Evidence Check